Ispire Technology Inc (ISPR)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEF 14A - Other definitive proxy statements

Ispire Technology Expands Into High-Growth Nicotine Pouch Market Through Strategic Joint Venture with Jincheng Pharma

Ispire Technology Expands Into High-Growth Nicotine Pouch Market Through Strategic Joint Venture with...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Ispire Technology Inc. Reports Financial Results for Fiscal Third Quarter 2026

Ispire Technology Inc. Reports Financial Results for Fiscal Third Quarter 2026 PR Newswire LOS ANGELES, May...

Ispire Technology Inc. Schedules Fiscal Third Quarter 2026 Earnings Conference Call

Ispire Technology Inc. Schedules Fiscal Third Quarter 2026 Earnings Conference Call PR Newswire LOS...

IKETech Wins "Privacy-Centric Age Assurance Solution of the Year," Recognized for Innovation at Global Industry Awards

IKETech Wins "Privacy-Centric Age Assurance Solution of the Year," Recognized for Innovation at Global...

IKE Tech Engages FDA on Next-Generation Compliance Infrastructure for ENDS

IKE Tech Engages FDA on Next-Generation Compliance Infrastructure for ENDS PR Newswire LOS ANGELES, April...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Ispire Highlights Economic Impact of New FDA Guidance on Flavored ENDS Unlocking a $50 Billion Market and Driving Significant Potential Asset Value

Ispire Highlights Economic Impact of New FDA Guidance on Flavored ENDS Unlocking a $50 Billion Market and...

Ispire Technology Inc. to Participate in the 38th Annual ROTH Conference

Ispire Technology Inc. to Participate in the 38th Annual ROTH Conference PR Newswire LOS ANGELES, March 11...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]